Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Robertson becomes Opthea’s first CCO

Plus: 4D Pharma, NeuShen, Mind, PolyPid and Biosion

January 3, 2022 10:53 PM UTC

Australian retinal disease company Opthea Ltd. (ASX:OPT; NASDAQ:OPT) hired Judith Robertson as its first CCO. Robertson previously held CCO positions at Eleusis Ltd. and Aerie Pharmaceuticals Inc. (NASDAQ:AERI), and had been on Opthea’s board since June — she relinquished the position concurrent with her new appointment.

4D pharma plc (LSE:DDDD; NASDAQ:LBPS) hired John Doyle as CFO. Doyle was previously CFO at Chiasma Inc. (NASDAQ:CHMA) and VP of finance and investor relations at Verastem Inc. (NASDAQ:VSTM). 4D is developing live biotherapeutics, a class of drug derived from the microbiome. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article